Navigation Links
The combination of monolithic columns and modern HPLC/MS/MS instrumentation for high chromatographic throughput and sensitive detection of beta-agonists

Beta-agonists are group A substances of the European guideline 93/257/EWG (revision 98/536/EG) having an anabolic effect and not licensed. Thus, they have to be determined in veterinarian samples like muscle, liver, retina, and urine. The coupling of High Pressure Liquid Chromatography (HPLC) and Electrospray Ionization Tandem Mass Spectrometry (ESI-MS-MS) seems to be the analytical method of choice for such thermally labile and polar substances. Classical HPLC/ESI-MS-MS instrumentation allows the determination with satisfying detection limits, accuracy, and reproducibility. Due to the high number of substances that have to be analyzed in a single run, longer chromatographic separation times have to be accepted. Monolithic columns are made of a single piece of porous silica with a defined pore structure. Thus, lower back pressure in the column allows the use of higher flow rates and flow gradients, without loss in chromatographic resolution. In the following work the possibility of increasing sample throughput and sensitivity using monolithic columns at higher flow rates and a modern mass spectrometer, which is optimized to work with such high flow rates is evaluated.

High Pressure Liquid Chromatography

: Agilent 1100 series binary pump, column oven, and well-plate autosampler

columns: Inertsil ODS-3 150x2.1 mm at a flow rate of 200 μL/min Merck Chromolith SpeedROD RP-18e 50x4.6 mm at flow rates of 1000 μL/min and 2000 μL/min

eluent A: H2O+5mM NH4formiate pH=4.0 eluent B: acetonitrile+5% H2O

gradients (A/B):

column oven temperature of 25C

injection of 20 μl Mass Spectrometry:

Applied Biosystems API 4000 LC/MS/MS System with Turbo V source in positive ion mode 500C at 200 μl/min 700C at 1000 and 2000 μl/min (without split)

detection
'"/>

Source:


Page: All 1 2

Related biology technology :

1. Generate Adenovirus Vectors in E. coli by Homologous Recombination with the AdEasy Adenoviral Vector System
2. HPLC/MS/MS Analysis of Bitter Acids in Hops and Beer
3. Determination of Polar Organophosphorus Pesticides in Aqueous Samples by Direct Injection Using HPLC/MS/MS
4. Detection of nitrofurane metabolites in food with HPLC/MS/MS
5. High-throughput gene expression analysis to screen for anti-asthma drugs
6. DirectPrep 96 Miniprep System for cost-effective, high-throughput plasmid DNA purification
7. Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000
8. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
9. A highly sensitive ATP-luminescence assay using VICTOR2 with the dispenser option
10. Monitoring transfection efficiency by green fluorescent protein (GFP) detection with the Agilent 2100 bioanalyzer
11. Apoptosis detection by annexin V and active caspase-3 with the Agilent 2100 bioanalyzer

Post Your Comments:
(Date:11/24/2009)... The New York investment bank...ASX:NEU) has agreed an AU$6.7 mil convertible note...tor. The private placement was arranged by KTA Cap...isor. , New York (PRWEB) ...stment bank KTA Capital, LLC ("KTA Capital&qu...
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCal...ill be presenting at the NASDAQ OMX conference on ...45 AM US/CST. Interested parties may listen via li... http://inve s tor.sig m a a ldrich.com/ ....s file. ,, About Sigma-Aldrich: Sigma-Ald...
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire... biopharmaceutical company focused on developing a..., announced today that Anthony DiTonno, President ...nt at the 21st Annual Piper Jaffray Health Care Co... York Palace Hotel in New York, New York. ,, M...
(Date:11/24/2009)... , , Primary efficacy endpoint has been m...nt endometrial cancer, , QUEBEC CITY, Nov. 24...ASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global...erapy and oncology, today announced positive effic...totoxic peptide conjugate, AEZS-108 (formerly AN-1...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...ances Nfocus device development team. , , PALO AL... Nfocus Neuromedical Inc. announced today the ap...ert O,Holla to its leadership team in the role of ...,Holla brings an unmatched wealth of regulatory an... 18 of his last 30 years in the industry in the ro...
...idone role in treatment of patients with IPF - , ...t all-oral combination in HCV - , , - Strong data...in HCV - , , BRISBANE, Calif. , April 30 InterM...s from operations for the first quarter ended Marc...he first quarter of 2009 of $42.0 million, or $1.0...
...armaceuticals, Inc. (Nasdaq: IDIX ), a biopharma...lopment of drugs for the treatment of human viral ...ts for the first quarter ended March 31, 2009. At ...d marketable securities totaled $64.5 million. , ...st quarter of 2009, the company announced that it ...
Other Biology Technology:Nfocus Neuromedical Appoints Robert O'Holla to Head Regulatory 2InterMune Reports First Quarter 2009 Financial Results and Business Highlights 2InterMune Reports First Quarter 2009 Financial Results and Business Highlights 3InterMune Reports First Quarter 2009 Financial Results and Business Highlights 4InterMune Reports First Quarter 2009 Financial Results and Business Highlights 5InterMune Reports First Quarter 2009 Financial Results and Business Highlights 6InterMune Reports First Quarter 2009 Financial Results and Business Highlights 7InterMune Reports First Quarter 2009 Financial Results and Business Highlights 8InterMune Reports First Quarter 2009 Financial Results and Business Highlights 9InterMune Reports First Quarter 2009 Financial Results and Business Highlights 10InterMune Reports First Quarter 2009 Financial Results and Business Highlights 11InterMune Reports First Quarter 2009 Financial Results and Business Highlights 12InterMune Reports First Quarter 2009 Financial Results and Business Highlights 13Idenix Pharmaceuticals Reports First Quarter Financial Results 2Idenix Pharmaceuticals Reports First Quarter Financial Results 3Idenix Pharmaceuticals Reports First Quarter Financial Results 4Idenix Pharmaceuticals Reports First Quarter Financial Results 5Idenix Pharmaceuticals Reports First Quarter Financial Results 6
(Date:11/24/2009)...ntists have crystallised a protein that may help g...e protein could be used by probiotic producers to ...efit to people. , "Probiotics need to interact wi...t, and if they attach to surfaces in the gut they ...rt their activity," says Dr Nathalie Juge from the...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wi...a report revealing that the last remaining populat...cantly due to the rising tide of poaching and habi... help inform Russian officials of what needs to be...d,s biggest cat. , The report was r...
(Date:11/24/2009)...s release is available in Spanish . , The p...r levels of inflammatory substances in the blood, ...s shown by a research project of the University of...scientist at the School of Pharmacy. , The proje...y in relation to the control of body weight and in...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Nonprofit Goes RVing to Promote Pet and Human Health 48962 1Nonprofit Goes RVing to Promote Pet and Human Health 48962 2Nonprofit Goes RVing to Promote Pet and Human Health 48962 3HPV Vaccine Acceptability Study Announces Results 48959 1HPV Vaccine Acceptability Study Announces Results 48959 2HPV Vaccine Acceptability Study Announces Results 48959 3Heart Association Warns of Surgery Risks in Obese 48956 1Heart Association Warns of Surgery Risks in Obese 48956 2
...Walter J. Lukiw, PhD, Associate Professor of Neuro...Center New Orleans, is the lead author of a paper ...on of a fragment of ribonucleic acid (RNA), once t...ng inflammation and the development of Alzheimer,s...146a-mediated inflammatory circuit in Alzheimer,s ...
...SANTA CRUZ, CA--An unusual microorganism discovere...k their understanding of how carbon and nitrogen c... by Jonathan Zehr, professor of ocean sciences at ...rized the new microbe by analyzing its genetic mat...to grow it in the laboratory. , Zehr said the ne...
...CHAPEL HILL Researchers from the University of No...ve been awarded almost $10 million to study the ma...y affect interactions between mothers and their in...dings will aid the development of new intervention... and prove valuable to others working in fields su...
Other Biology News:LSUHSC research identifies key contributor to Alzheimer's disease process 2Mysterious microbe may play important role in ocean ecology 2Mysterious microbe may play important role in ocean ecology 3UNC, Yale partner to study effects of cocaine use on mother-infant relationships 2
Goat Anti-KOR-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
T7Select1-1 OrientExpress cDNA Cloning System Random Primer from Novagen
Goat Anti-VAP-1 (S-13) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
... atoms at the 3, 3', 4, and 4' positions. It is in...ntification of Prostaglandin E2 (PGE2) by GC- or L...clooxygenase products of arachidonic acid and one ...s activity influences inflammation, fertility and ...
Biology Products: